Duration of Antibiotic Therapy for Escherichia coli Bacteremia in Infants With Normal Cerebrospinal Fluid Studies and Without Meningitis.

Read full text
Authors: Ashley Stark, Veronica Quiett, Thomas Roberts, Rachel Rockwell, Veeral Nalin Tolia, M. Jay Campbell, Kanecia O. Zimmerman, Daniel K. Benjamin, Rachel G. Greenberg, Angelique E Boutzoukas
Cited by: 0

Abstract

OBJECTIVE: bacteremia with reliable, normal cerebrospinal fluid (CSF) studies and without meningitis is unknown. We evaluated whether treatment duration is associated with infection recurrence or mortality in these infants. METHODS: bacteremia. Exclusion criteria included absence of CSF test results, CSF pleocytosis, positive culture or Gram stain from the CSF, delayed antimicrobial initiation (>2 days), or death/discharge during therapy. Antibiotic duration was categorized as 14 days. Univariable analysis and multivariable logistic regression were used to assess associations between antibiotic duration and 30-day and in-hospital mortality, recurrence of infection, and the combined outcome of recurrence of infection or 30-day mortality. Sensitivity analysis excluded courses

Fields of Study & Subjects

Neonatal and Maternal Infections Antibiotics Pharmacokinetics and Efficacy Sepsis Diagnosis and Treatment

Publication details

Journal / source
Europe PMC (PubMed Central)
Volume
31
Issue
1
Pages
131–137
Publication date
1 February 2026
Language
EN